Investment briefing

Full year 2023 report on the state of longevity investment: the numbers, the sectors, the top deals, the key players and the outlook for 2024:
Annual longevity investment report 2023
Interim data release: November 2023:
Longevity Clinics Survey 2023
Read now
Edging ahead in Q3 but still held back:
Q3 2023: longevity investment report
Read now
Edging ahead in Q2 but still held back:
Q2 2023: longevity investment report
Read now
Investment review for January to March 2023. “If you’re going through hell, keep going.” Winston Churchill:
Q1 2023: longevity investment report
Read now
Full year 2022 report on the state of longevity investment: the numbers, the sectors, the top deals, the key players and the outlook for 2023:
Annual longevity investment report 2022
Read now
Disease management to disease modification – removing plaque to undo atherosclerosis:
Atherosclerosis
Read now
Delaying the menopause to increase women’s healthspan:
Reproductive longevity
Read now
Leading a new era of personalised, preventative health and optimal aging:
Longevity diagnostics
Read now
Supplementing your Longevity supplement knowledge:
Longevity supplements
Read now
Managing senescent cells to drive human longevity:
Senotherapeutics
Read now

News

Alzheon lands $100m to advance oral Alzheimer’s drug towards commercialization

Funding to complete ongoing Phase 3 trial and commercial launch of first

Founders Longevity Forum – insights and highlights

Experts discuss breakthroughs and challenges in longevity science, from women’s health to

Hevolution announces $400 million surge in healthspan funding

Global nonprofit foundation awards healthspan research funding to Albert Einstein College of

Acorn Biolabs lands $8m for follicle-based stem cell cryopreservation service

Hair-follicle derived stem cell banking service allows individuals to preserve their cells